SOL S.p.A. Stock London S.E.

Equities

0NJP

IT0001206769

Commodity Chemicals

Market Closed - London S.E. 12:10:10 2024-01-10 EST 5-day change 1st Jan Change
27 EUR -0.58% Intraday chart for SOL S.p.A. +4.34% +16.19%

Financials

Sales 2024 * 1.59B 1.72B 2.34B Sales 2025 * 1.7B 1.85B 2.52B Capitalization 3.03B 3.29B 4.48B
Net income 2024 * 162M 176M 239M Net income 2025 * 173M 188M 256M EV / Sales 2024 * 2.2 x
Net Debt 2024 * 459M 498M 678M Net Debt 2025 * 485M 526M 717M EV / Sales 2025 * 2.06 x
P/E ratio 2024 *
18.8 x
P/E ratio 2025 *
17.5 x
Employees 6,372
Yield 2024 *
1.35%
Yield 2025 *
1.44%
Free-Float 36.98%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.81%
1 week+4.34%
Current month+0.00%
1 month-10.81%
3 months+10.44%
6 months+20.08%
Current year+16.19%
More quotes
1 week
27.00
Extreme 27
32.95
1 month
27.00
Extreme 27
36.15
Current year
25.69
Extreme 25.6866
36.15
1 year
24.25
Extreme 24.25
36.15
3 years
15.42
Extreme 15.42
36.15
5 years
10.51
Extreme 10.5077
36.15
10 years
5.91
Extreme 5.911
36.15
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 90-09-03
Chief Executive Officer 66 90-05-14
Investor Relations Contact - -
Members of the board TitleAgeSince
Chief Executive Officer 66 90-05-14
Chief Executive Officer 62 90-09-03
Director/Board Member 65 98-04-26
More insiders
Date Price Change Volume
24-05-31 32.24 +1.81% 6,737
24-05-30 31.67 +1.66% 9,823
24-05-28 31.15 +0.81% 1
24-05-24 30.9 -3.33% 14

Delayed Quote London S.E., January 10, 2024 at 12:10 pm

More quotes
SOL SpA is an Italy-based company primarily engaged in the research, production and distribution of industrial, pure and medicinal gases. It is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
33.4 EUR
Average target price
38 EUR
Spread / Average Target
+13.77%
Consensus

Annual profits - Rate of surprise